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Exogenous ATP activates purinoreceptors on the cell surface
that regulate diverse cellular functions, including mucous cell
secretion in the respiratory epithelium. In this study, ATP
increased MUC5AC mRNA in primary human nasal epithelial
cells and in NCI-H292 pulmonary adenocarcinoma cells in
vitro. ATP-induced MUC5AC mRNA was mediated by phos-
pholipaseC3.Adominant-negativemutation in thePDZbind-
ing domain of PLC3 inhibited ATP-induced MUC5AC gene
expression. ATP sequentially activated the phosphorylation of
Akt, ERK1/2, p38, RSK1, and cAMP-responding element-bind-
ing protein (CREB) in a protein kinase C-independent manner.
ATP-induced MUC5AC mRNA levels were regulated by CREB
via direct interaction with c-Ets1 on the MUC5AC gene pro-
moter (located938 to930). Effects of CREB and c-Ets1 were
additive. Inhibition of either CREB or c-Ets1 inhibited ATP-
induced MUC5AC gene expression. Stimulation with ATP
caused the direct binding of CREB and c-Ets1 to the MUC5AC
promoter, increasing the phosphorylation of c-Ets1. Chromatin
immunoprecipitation assays demonstrated that in the presence
of ATP, both c-Ets1 and CREB bound to the MUC5AC pro-
moter. The effects of exogenous ATP onMUC5AC gene expres-
sion are mediated by a complex regulatory cascade controlling
interactions between CREB and c-Ets1 that bind to a promoter
element in the MUC5AC gene enhancing MUC5AC gene tran-
scription. ATP-dependent activation ofMUC5AC gene expres-
sion viaCREB-c-Ets1may contribute tomucous cell hypersecre-
tion associated with common respiratory disorders.
Mucus hypersecretion in the airway epithelium is a major
characteristic of a number of respiratory diseases, including
rhinitis, sinusitis, asthma, chronic obstructive pulmonary dis-
ease, and cystic fibrosis (1). Because bacteria, cytokines, and
stimulants can interact with host epithelial cells and activate
intracellular signaling pathways thereby causing a selective
increase in specific mucin gene expression and Mucin pro-
duction, it is important to clarify the molecular mechanism
of these interactions. An understanding of the mechanisms
that lead to increased mucus secretion in respiratory dis-
eases is critical to improve future therapies.MUC5AC is one
of the major mucin genes in the human respiratory tract, so
clarification of the mechanisms regulating MUC5AC gene
expression is essential for identifying strategies to prevent
airway mucus hypersecretion.
Until now, there have been no reports on ATP-induced
MUC5AC gene expression in the airway, because most of the
studies on ATP have taken an electrophysiological approach to
determine the role of agonist in inducingMucin secretion (2, 3).
Thus, the mechanism by which ATP can induce mucin gene
expression in the airway remains unclear. ATP signaling is pro-
cessed through purinergic receptors. P2Y is a G-protein-cou-
pled receptor, and P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 receptors
are highly expressed in NHNE cells (4). P2Y couples to the
G-protein subtype, Gq, and the Gq family activates PLC
upon stimulation with ligands (5). PLC isotypes have a long
C-terminal region (400 residues) that has a relatively low
homology among family members (6), and this C-terminal
region (residues 903–1142 of PLC1) is required for binding
and stimulation by Gq (7). Moreover, PLC isotypes are short
consensus sequences known as postsynaptic density-95/disc
large/ZO-1 (PDZ)-bindingmotifs. PDZdomains exist in a large
number of multifunctional proteins that mediate protein-pro-
tein interactions at the postsynaptic density in neurons and
junctional complexes in epithelia (8). However, themechanism
of PLC3-mediated MUC5AC gene expression and the signal
molecules involved, especially in the downstream signaling of
MAPK,2 have not yet been demonstrated.
A role for E26 transformation-specific (Ets) cis-sequences in
the promoter of MUC5AC for ATP-induced MUC5AC gene
expression has not yet been identified. c-Ets1 is a member of a
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logical processes (9, 10). The Ets domain recognizes and binds
to a GGAA purine-rich core sequence found in the promoters
of specific genes. The interaction between nuclear proteins is
essential for transcriptional regulation. Furthermore, protein-
protein interactions are involved in every step of cell signaling,
including receiving of the signal, selection of the target genes,
regulation of DNA binding ability, regulation of transcriptional
activity, and turnover of transcription factors (9). We therefore
examined the role of c-Ets1 in signal transduction facilitated by
interactions with other nuclear transcription factors.
Because increasedMUC5AC gene expression during inflam-
mation plays an important role in the pathogenesis of airway
diseases, we examined whether extracellular ATP up-regulates
MUC5AC gene expression by activating specific signal trans-
duction pathways. Here, we show that PLC3, Akt, MAPK,
RSK1, and CREB are sequentially essential for ATP-induced
MUC5AC gene expression in airway epithelial cells. We also
show that CREBmediates the phosphorylation of c-Ets1, which
leads to the formation of a protein complex that binds the
MUC5AC promoter.
EXPERIMENTAL PROCEDURES
Materials—ATP and lipopolysaccharide were purchased
from Sigma. All antibodies were purchased from Cell Signaling
(Beverly, MA), except for the antibody for c-Ets1, which was
from Santa Cruz Biotechnology (Santa Cruz, CA). All of the
PLC3 isotypes were kindly provided by Dr. Pann-Ghill Suh
(Department of Life Science, Pohang University of Science and
Technology, Pohang, Korea). PLC3 isotypes in pcDNA3.1
were constructed from the cDNA of each of the mutated
PLC3 isotypes. Each of the individual residues of the PDZ-
binding motif (NTQL) of PLC3 were mutated to Ala codons
(8). The construct encoding c-Ets1 was kindly provided by Dr.
Young-Hyuck Im (Biomedical Research Institute, Samsung
Medical Center, Sungkyunkwan University School of Medi-
cine, Seoul, Korea). All siRNAs were synthesized by Bioneer
(Daejeon, Korea) (Table 1).
Cell Cultures—Passage 2 NHNE cells (2  105 cells/well)
were seeded in 0.5 ml of culture medium on Transwell clear
culture inserts (24.5 mm, 0.45-m pore size; Costar, Cam-
bridge, MA). Cells were cultured in a 1:1 mixture of bronchial
epithelial cell growth medium and Dulbecco’s modified Eagle’s
medium containing all the supplements described previously
(12). Cultures were grown while submerged for the first 9 days,
during which time the culture medium was changed on day 1
and every other day thereafter. The air-liquid interface was cre-
ated on day 9 by removing the apical medium and feeding the
cultures only from the basal compartment. The human lung
mucoepidermoid carcinoma cell line (NCI-H292) was pur-
chased from the American Type Culture Collection (CRL-
1848; Manassas, VA) and cultured in RPMI 1640 medium
(Invitrogen) supplemented with 10% fetal bovine serum in the
presence of penicillin/streptomycin at 37 °C in a humidified
chamber with 5% CO2. For serum deprivation, confluent cells
were washed twice with phosphate-buffered saline and recul-
tured in RPMI 1640 medium with 0.2% fetal bovine serum.
RT-PCR—Real time PCR was performed using an iQ iCycler
detection system (Bio-Rad) with iQ SYBR Green Supermix.
Reactions were performed in a total volume of 20 l, which
included 10 l of 2 SYBR Green PCR Master Mix, 300 nM of
each primer, and 1 l of previously reverse-transcribed cDNA
template. The following primers were used:MUC5AC, forward
5-CAGCCACGTCCCCTTCAATA-3 and reverse 5-ACCG-
CATTTGGGCATCC-3; and 2-microglobulin, used as a
reference for normalization, forward 5-CGCTCCGTGGCCT-
TAGC-3 and reverse 5-GAGTACGCTGGATAGCCTCCA-
3. Real timeRT-PCRwas performedon aMiniOption real time
PCR detection system (Bio-Rad). Parameters were 95 °C for 10
min, followed by 40 cycles of 95 °C for 15 s, 60 °C for 30 s, and
72 °C for 30 s. All reactions were performed in triplicate. The
relative quantity of MUC5AC mRNA was obtained using the
comparative cycle thresholdmethod and was normalized using
2-microglobulin as an endogenous control.
Western Blot Analysis and Immunoprecipitation—NCI-
H292 cells were grown to confluence in 6-well plates. After
treatment with ATP, cells were lysed with 2 lysis buffer (250
mM Tris-Cl (pH 6.5), 2% SDS, 4% -mercaptoethanol, 0.02%
bromphenol blue, 10% glycerol). Equal amounts of whole cell
lysates were resolved by 10–15% SDS-PAGE and transferred to
polyvinylidene difluoride membranes (Millipore, Bedford,
MA). Membranes were blocked with 5% skim milk in Tris-
buffered saline (50mMTris-Cl (pH7.5), 150mMNaCl) for 2 h at
room temperature. Blots were then incubated overnight with
primary antibody in TTBS (0.5% Tween 20 in Tris-buffered
saline). After washing with TTBS, blots were further incubated
for 45min at room temperature with anti-rabbit or anti-mouse
antibody (Cell Signaling) in TTBS and visualized using the ECL
system (GE Healthcare). For immunoprecipitation, cells were
washed with ice-cold phosphate-buffered saline, harvested by
scraping into lysis buffer (25 mM HEPES, 150 mM NaCl, 0.5%
Nonidet P-40, 1 mM EDTA, 1 mM EGTA, protease inhibitor
tablet (Complete Mini; Roche Applied Science)), sonicated
(four times each for 5 s), and centrifuged at 12,000  g for 15
min. Supernatant lysates (230 l) were pre-cleared with Gam-
mabind G-Sepharose (GE Healthcare) for 30 min at 4 °C. Fol-
lowing centrifugation, anti-Ets-1 antisera were added to pre-
cleared lysates, incubated for 14 h at 4 °C, andmicrocentrifuged
at 4 °C. The pellet was washed three times with lysis buffer.
GST Pulldown Assay—GST fusion proteins were expressed
in andpurified frombacteria using a glutathione affinitymatrix.
The GST fusion proteins were eluted from thematrix with glu-
tathione and desalted by centrifugation (Centricon YM-3; Mil-
lipore). For interaction assays with cell lysates, the GST fusion
protein (250 nM) was incubated with cell lysate (4 mg of pro-
tein/ml) for 1 h at 24 °C in a total volume of 250 l of buffer (20
mM Tris (pH 7.5), 70 mM NaCl, 1 mM dithiothreitol, 0.6 mM
TABLE 1
siRNA sequences for indicated target genes
Gene siRNA sequence(3 linker, dTdT)
GenBankTM
accession No.
Akt1 GACAACCGCCAUCCAGACU NM_001014431
ERK1 CAGAUCUUUACAAGCUCUU NM_002745
p38 CUGUUGACUGGAAGAACAU NM_001315
RSK1 CUGAUGACACCUUCUACUU NM_001006665
CREB UCAAGGAGGCCUUCCUACA NM_004379
c-Ets1 GCUGACCUCAAUAAGGACA NM_005238
Control CCUACGCCACCAAUUUCGU
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EDTA). A volume of 12.5 l of packed glutathione-Sepharose
slurry was added, and the mixture was rotated at 4 °C for 20
min, after which the affinity matrix was pelleted and washed
three times with 500 l of incubation buffer. Proteins retained
on the matrix were solubilized in 2 Laemmli loading buffer
and separated by electrophoresis.
Cell Transfection and Luciferase Assays—For luciferase
assays, cells were plated in 12-well plates 1 day prior to trans-
fection using FuGENE 6 (Roche Applied Science) according to
the manufacturer’s instructions. Approximately 24 h after
transfection, cells were treated with ATP for 24 h. For the
MUC5AC promoter-driven luciferase assay, cells were main-
tained in serum-free RPMImedia for 16–18 h before treatment
with ATP. Cells were harvested 24 h after ATP treatment, and
the luciferase activity in cell extracts was determined using a
luciferase assay system according to the manufacturer’s
instructions (Promega; Madison, WI). Luciferase values were
normalized to -galactosidase. Transfection experiments were
performed in duplicate and repeated at least three times.
Chromatin Immunoprecipitation (ChIP) Assay—ChIP assays
were performed with the EZ ChIP assay kit and protocol
(Upstate). A total of 4.5 107 cells were fixed in 1% formalde-
hyde at room temperature for 20min. Isolated nuclei were lysed
followed by chromatin shearingwith the enzymatic shearing kit
(Active Motif; Carlsbad, CA). A rabbit IgG antibody (Sigma)
was used as the control. After reverse cross-linking and DNA
purification, DNA from input (1:20 diluted) or immunoprecipi-
tated samples were assayed by PCR, and the products were sep-
arated by agarose gel electrophoresis. The following were the
primers used to detect the c-Ets1 element in theMUC5AC pro-
moter: forward, GTGTTCATCACACAACAGCACC, and
reverse, TCCAGAAATGCTCAGTACCCTCTG. This PCR
product did not contain a CRE site. Control primers were for a
site 2,200 bp upstream of c-Ets1 as follows: forward,
GCCCCACTGACATAACCACCTGGC, and reverse, GGT-
CTGACTCGACCAGGTGTAGCC.
Statistical Analysis—The data are presented as the means
S.D. of at least three independent experiments. Where appro-
priate, statistical differences were assessed byWilcoxonMann-
Whitney tests. A p value less than
0.05 was considered statistically
significant.
RESULTS
Extracellular ATP Induces
MUC5AC Gene Expression in Nor-
mal Human Nasal Epithelial Cells
and NCI-H292 Cells—There has
been no report on the induction of
MUC5AC gene expression by extra-
cellular ATP as ATP studies have
primarily focused on electrophysi-
ology. We examined whether ATP
could induce mucin gene expres-
sion, because ATP stimulates
Mucin secretion, and could partici-
pate as an inflammation mediator
that can send a signal to nearby cells.
First, to examine if ATP increasesMUC5AC gene expression in
normal human nasal epithelial (NHNE) cells, real time PCR
analysis was performed. NHNE cells were treated with various
doses of ATP for 24 h. Increased MUC5AC gene expression
occurred in a dose-dependent manner with an EC50 value of
9.4 0.15M (Fig. 1A), and as a result, 10MATPwas used for
all the subsequent experiments. In addition, MUC5AC gene
expression increased in a time-dependent manner for up to
12 h after ATP treatment and then reached a plateau (Fig. 1B).
These results show that extracellular ATP induces MUC5AC
gene expression in a dose- and time-dependent manner in
NHNE cells. When the same experiments (Fig. 1) were per-
formed using NCI-H292 cells, a human lung mucoepidermoid
carcinoma cell line, the results were the same (data not shown).
Thus, we used NCI-H292 cells for all subsequent molecular
experiments.
PLC3 and Akt Are Essential for ATP-induced MUC5AC
Gene Expression—To determine which molecules are involved
in the downstream signaling of Gq in ATP-inducedMUC5AC
gene expression, we investigated phospholipase C (PLC) 3
(Fig. 2A). The phosphorylation of PLC3 by ATP reached a
maximum at 5 min. Interestingly, there are short consensus
sequences known as postsynaptic density-95/discs large/ZO-1
(PDZ)-binding motifs that consist of the amino acids -X(S/
T)X(V/L)-COOH at the immediate C terminus of the PLC3
isotype (13). The PDZdomain of PLC3 binds four amino acids
of target proteins to the C terminus (8, 14, 15). To identify
whether the PDZ domain of the C terminus of PLC3 plays an
important role in ATP-induced MUC5AC gene expression,
each of the last four amino acid residues of PLC3
(1231NTQL1234-COOH) was mutated to Ala. When treated
with ATP, cells transfected with the construct expressing wild-
type PLC3 showed an increase inMUC5AC gene expression,
whereas the cells transfected with the construct expressing the
dominant-negative mutant PLC3 NTQA (L1234A), but not
PLC3 ATQL (N1231A), NAQL (T1232A), or NTAL
(Q1233A), showed a dramatic suppression of MUC5AC gene
expression (Fig. 2B). This result indicates that the Leu residue
of the PDZ domain in PLC3 is essential for interacting with
FIGURE 1. Effect of extracellular ATP onMUC5AC gene expression in NHNE cells. NHNE cells were treated
for 24 h with exogenous ATP at the indicated concentrations (A) and times (B). Cell lysates were harvested for
real time quantitative PCR. *, p  0.05 compared with control (vehicle). Data are presented as mean  S.D.
values of three independent experiments. The figures are representative of three independent experiments.
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FIGURE 2.PLC3 andAkt, but not PKC, are essential for ATP-mediatedMUC5ACgene expression.A, confluent and quiescent NCI-H292 cells were treated
withATP (10M) for the indicated times, thencell lysateswereharvestedandanalyzedbyWesternblot usingphospho-specific PLC3antibody.Actinwasused
as a loading control. B, cells were transiently transfected with wild-type (1231NTQL1234) or dominant-negative PLC3 ATQL (N1231A), NAQL (T1232A), NTAL
(Q1233A), or NTQA (L1234A) construct. Each of the individual residues of the PDZ-bindingmotif (NTQL) of PLC3weremutated to Ala, respectively. Cells were
serum-starved overnight and then treated with ATP for 24 h, after which cell lysates were harvested for real time quantitative RT-PCR. con, control. *, p 0.05
compared with control (vehicle); **, p 0.05 compared with ATP treatment only. C, after cells were transfected with a wild-type PLC3 or dominant-negative
PLC3 NTQA construct, cells were treated with ATP for 5 min prior to the collection of cell lysates for Western blot analysis. Actin was used as a total protein
loading control. D, quiescent NCI-H292 cells were treated with ATP for the indicated times and then cell lysates were harvested by Western blot using
phospho-specific PKC or Akt antibody. Actin was used as a loading control. E, cells were transiently transfected with a wild-type or siRNA construct of Akt.
Cells were treated with ATP for 5 min, after which cell lysates were harvested for Western blot analysis using phospho-specific antibodies. F, after cells
were transfected with a wild-type or siRNA construct of Akt, cells were treated with ATP for 24 h prior to the collection of total RNA for real time
quantitative RT-PCR. *, p 0.05 compared with control (vehicle); **, p 0.05 compared with ATP treatment only. The figures are representative of three
independent experiments.
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some target signaling molecule(s) to induce MUC5AC gene
expression after ATP treatment. In addition, phosphorylation
of PLC3 andAkt were suppressed when cells were transfected
with the PLC3 NTQA dominant-negative construct (Fig. 2C).
Even though many reports have shown that PLC3 regulates
PKC activation, it appears that PKC is not involved in ATP-
induced signaling (Fig. 2D). Interestingly, whereas PKC phos-
phorylation was not altered by ATP, Akt phosphorylation
reached amaximumat 5min.This resultmay indicate thatATP
signaling is mediated through PLC3 and Akt. To examine the
role of Akt in ATP-induced MUC5AC gene expression in our
system, we used both wild-type Akt and siRNA-Akt constructs.
Wild-type Akt activated the phosphorylation of Akt, ERK1/2,
and p38MAPK, whereas an siRNA-Akt construct inhibited the
phosphorylation of Akt, ERK1/2, and p38 MAPK but not
PLC3. In addition, Akt levels were increased in cells trans-
fected with construct expressing wild-type Akt and decreased
in cells transfected with siRNA-Akt. However,MUC5AC gene
expression increased when cells were transfected with wild-
type Akt compared with treatment with ATP alone (Fig. 2F),
andMUC5AC gene expression was significantly suppressed by
siRNA-Akt. These results show that PLC3 and Akt appear to
function together in a pathway mediating ATP-induced
MUC5AC gene expression and Akt functions downstream of
PLC3 in NCI-H292 cells.
Both ERK1/2 and p38MAPKs Are Essential for ATP-induced
MUC5AC Gene Expression—We also investigated whether the
ERK1/2 or p38 pathways are involved in ATP-inducedMUC5AC
gene expression. The phosphorylation of ERK1/2 and p38 peaked
at 5minafterATP treatment (Fig. 3A), andnochange inphospho-
rylation of JNKwas observed. To investigate the possible involve-
ment of ERK1/2 andp38MAPKs inATP-inducedMUC5AC gene
expression, either the siRNA-ERK1/2or siRNA-p38constructwas
applied before treatmentwithATP.Western blot analysis showed
that the siRNA-ERK1/2 and siRNA-p38 constructs clearly inhibit
ERK1/2 and p38MAPK, respectively (Fig. 3B).We also examined
the transcript levelofMUC5ACbyperformingreal timePCRanal-
ysis (Fig. 3C). Whereas ATP-inducedMUC5AC gene expression
was higher in cells transfected with wild-type constructs com-
pared with cells treated with ATP alone,MUC5AC gene expres-
sionwas significantly suppressedbyboth siRNAconstructs.These
results suggest that both ERK1/2 and p38MAPKs may be down-
stream signaling proteins of Akt and may be essential for ATP-
inducedMUC5AC gene expression.
FIGURE 3. ERK1/2 andp38MAPKs are essential for ATP-mediatedMUC5ACgene expression. A, confluent and quiescent NCI-H292 cells were treatedwith
ATP for the indicated times, and then cell lysates were harvested and analyzed by Western blot using phospho-specific antibodies. B, cells were transiently
transfected with wild-type or siRNA construct of ERK1/2 and p38 MAPKs, respectively. Cells were serum-starved overnight and then treated with ATP (10 M)
for 5min or 24 h, after which cell lysates were harvested forWestern blot analysis or real time quantitative RT-PCR (C). Actin was used as a total protein loading
control. *, p 0.05 comparedwith control (vehicle); **, p 0.05 comparedwithwild-type construct treated byATP. con, control. The figures are representative
of three independent experiments.
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ATP-induced MUC5AC Gene Expression Is Mediated by
RSK1 and CREB Sequentially but Not byMSK1—To determine
which molecules are involved in the nuclear signaling of ATP-
inducedMUC5AC gene expression,we examinedmitogen- and
stress-activated protein kinase (MSK) 1, p90 ribosomal S6 pro-
tein kinase (RSK) 1, and cAMP-response element-binding pro-
tein (CREB), which are all associated with calcium activation.
As seen in Fig. 4A, alterations were seen in the phosphorylation
status of RSK1 and CREB after ATP treatment, but no changes
were observed for MSK1. RSK1 phosphorylation peaked at 5
min and then decreased back to base line 20 min after ATP
treatment. This is in contrast to findings for other proinflam-
matory mediators like IL-1 or tumor necrosis factor-, where
RSK1 peaked 30 min after treatment (16), demonstrating that
phosphorylation of RSK1 occurs more rapidly when stimulated
by ATP.
To examine the signaling molecules downstream of RSK1,
we investigated CREB, a well known downstream molecule of
RSK1. Transient phosphorylation of CREB was observed upon
stimulation with ATP, reaching a maximum peak at 5–10 min.
These results show the possible involvement of RSK1 and
CREB in ATP-induced signaling during inflammation. To con-
firm the role of RSK1 and CREB at the cellular level, we used
constructs expressingwild-type ERK1/2, p38, RSK1, andCREB,
and we also used specific siRNAs for these proteins. Interest-
ingly, inhibition of either ERK1/2 or p38 MAPK decreased
RSK1 phosphorylation (Fig. 4B), suggesting that RSK1 activity
is simultaneously controlled by both ERK1/2 and p38 MAPKs
and that RSK1 may act as a downstream signaling molecule of
these MAPKs. In addition, CREB phosphorylation was
decreased by siRNA-RSK1. These results suggest that RSK1
acts upstream of CREB. Furthermore, siRNA-RSK1 and
siRNA-CREB constructs also decreased the steady-state level of
MUC5AC mRNA expression in NCI-H292 cells (Fig. 4C).
These results indicate that RSK1 and CREB are controlled by
ERK1/2 and p38 MAPKs, sequentially, and may be involved in
ATP-inducedMUC5AC gene expression in the nucleus.
cis-Acting Regulatory Element, c-Ets1, Mediates ATP-
induced MUC5AC Transcriptional Activity—To identify the
ATP-responsive region within the MUC5AC promoter, cells
were transiently transfected with various deletion mutants and
treated with ATP for 24 h. ATP selectively increased the lucif-
erase activity of the 950/1 region of the MUC5AC pro-
moter. ATP-induced luciferase activity of the929/1 region
of theMUC5AC promoter was lower than that of the950/1
regions, indicating that the950/929 region of theMUC5AC
promoter may be necessary for its response to ATP (Fig. 5A).
Interestingly, there is no CRE site in the 950/929 region.
This finding suggests that a transcription factor other than
CREB may have a crucial role. To identify the ATP-responsive
cis-element in the MUC5AC promoter, we used the
TFSEARCH version 1.3 data base. This search strategy identi-
fied a candidate, c-Ets1 (score 91.2; threshold, 90.0). To date,
more than 25 mammalian Ets family members have been char-
acterized and are known to control important biological pro-
cesses, including cellular proliferation, differentiation, lympho-
cyte development and activation, and transformation by
recognizing a GCA core motif in the promoter or enhancer of
their target genes (9). To further investigate whether c-Ets1,
which was found within the 938/930 region of the
MUC5AC promoter, might act as a cis-element, three con-
structs for selectivemutagenesis of the c-Ets1-binding site were
generated. Only the 932 mutant construct decreased the
responsiveness of the wild-typeMUC5AC promoter construct
(Fig. 5B). However, neither the 935 nor 938 mutant con-
structs were able to suppress luciferase activity. These results
suggest that c-Ets1 (938/930 region) in the regulatory
region of the MUC5AC promoter may be critical for ATP-in-
duced up-regulation of MUC5AC transcriptional activity. To
FIGURE 4. RSK1 and CREB, but not MSK1, act as downstream signaling
mediators of ERK1/2 and p38 MAPKs to induce ATP-mediatedMUC5AC
gene expression. A, confluent and quiescent NCI-H292 cells were treated
withATP for the indicated times, and then cell lysateswere analyzedbyWest-
ern blot using phospho-specific antibodies. B, cells were transiently trans-
fected with wild-type or siRNA construct of ERK1/2, p38, RSK1, and CREB,
respectively. Cells were serum-starved overnight and then treated with ATP
for 5 min or 24 h, after which cell lysates were harvested for Western blot
analysis or real time quantitative RT-PCR (C). Actin was used as a total protein
loading control. *, p  0.05 compared with control (vehicle); **, p  0.05
comparedwithwild-typeconstruct treatedbyATP. con, control. These figures
are representative of three independent experiments.
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investigate whether c-Ets-mediated activity was affected by
CREB, we co-transfected the950/1 construct as a wild type,
a 929/1 construct that did not contain a c-Ets1 site, or a
932m construct as a site-directedmutation of c-Ets1 site with
either wild-type CREB, siRNA-CREB, wild-type c-Ets1, or
siRNA-c-Ets1, respectively. The activity of the 950/1 con-
struct was not affected by wild-type CREB but was decreased in
the presence of siRNA-CREB. In addition, the activity of the
950/1 construct increased with
the wild-type c-Ets1 but decreased
with the siRNA-c-Ets1. However,
the activity of the 929/1 con-
struct only slightly increased with
wild-type CREB and decreased with
the siRNA-CREB. The932m con-
struct activity was not affected by
these genes. These results suggest
that the activity of the 950/1
construct is mainly regulated by
c-Ets and is partially affected by
CREB.
c-Ets1 Up-regulates ATP-induced
MUC5AC Gene Expression through
Interaction with CREB—To exam-
ine whether c-Ets1 affects ATP-in-
duced MUC5AC gene expression,
transient transfection with a plas-
mid construct encoding either wild-
type c-Ets1 or siRNA-c-Ets1 was
performed (Fig. 6A). Whereas wild-
type c-Ets1 up-regulated ATP-in-
duced MUC5AC gene expression,
siRNA-c-Ets1 attenuatedMUC5AC
gene expression, demonstrating
that c-Ets1 may play an important
role in ATP-induced MUC5AC
gene expression. Next, to further
investigate the effect of ATP on
c-Ets1 activity, cells were treated
withATP in a time-dependentman-
ner, and c-Ets1 phosphorylation
was analyzed by Western blot anal-
ysis using a specific antibody against
phosphorylated c-Ets1 (Ser(P)-282).
c-Ets1 was rapidly phosphorylated
10 min after ATP treatment, and
this persisted for up to 15 min (Fig.
6B). In addition, ATP could induce
CREB and c-Ets1 activation in
NHNE cells and in vivo (data not
shown). Furthermore, to determine
the effect of RSK1 or CREB on the
phosphorylation of c-Ets1, we used
both wild-type and siRNA con-
structs of RSK1, CREB, and c-Ets1
(Fig. 6C). Interestingly, siRNA-
CREB suppressed the phosphoryla-
tion of c-Ets1, whereas siRNA of
c-Ets1 had no effect the phosphorylation of CREB. In addition,
RSK1 did not affect the phosphorylation of c-Ets1. These
results suggest that CREB may activate c-Ets1 in an RSK1-in-
dependent manner. Furthermore, we investigated the relation-
ship between c-Ets1 andCREB inATP-inducedMUC5AC gene
expression because both c-Ets1 andCREB are transcription fac-
tors, and c-Ets1 activity is selectively regulated by interactions
with different transcription factors such as AP-1, NF-B, and
FIGURE 5. ATP-induced c-Ets1 activation mediatesMUC5AC transcription via the cis-acting c-Ets1 regu-
latorymotif.A, cellswere transiently transfectedwith severalMUC5ACpromoter luciferase reporter constructs
and stimulated with ATP (10 M) for 24 h. Cell lysates were harvested and reporter assays were performed
according to the manufacturer’s instructions (see “Experimental Procedures”). *, p  0.05 compared with
1076/1 reporter construct. B, site-directed selectivemutagenesis was performed to construct c-Ets1-bind-
ing site mutants as indicated. Luciferase activities are shown after correction for transfection efficiency using
the-galactosidase activity of the cell lysates. Values shown aremeans S.D. of experiments performed three
ormore times. *,p0.05 comparedwithwild-type reporter construct.C, cellswere transiently transfectedwith
a950/1,929/1, or932m/1 reporter constructs in combination with either wild-type or siRNA con-
structs for CREB or c-Ets1. Cells were stimulated with ATP (10 M) for 24 h. Cell lysates were harvested and
reporter assays performed according to themanufacturer’s instructions. *, p 0.05 compared with ATP treat-
ment; **, p  0.05 compared with wild-type c-Ets1 treated by ATP. These figures are representative of three
independent experiments.
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Pax family members (9). To explore the interaction between
c-Ets1 and CREB using in vitro binding assays, we generated
wild-type CREB andmutant CREB (S133A) as GST fusion pro-
teins. These GST fusion proteins were incubated with NCI-
H292 cell lysates obtained after stimulation with ATP for 10
min. As shown in Fig. 6D, CREB interacted with c-Ets1 and
activated the phosphorylation of c-Ets1, whereas CREB S133A
did not interact with c-Ets1. Furthermore, cell extracts
obtained after stimulation with ATPwere immunoprecipitated
with anti-c-Ets1 and then blottedwith the indicated antibodies.
Complex formation between c-Ets1
and CREB, but not c-Ets1 and CBP,
was observed 5–10 min after expo-
sure to ATP (Fig. 6E). These results
are noteworthy because several
reports have shown that c-Ets1 can
bind to CBP/p300 but not to CREB
(10, 17, 18). Thus, our results sug-
gest that CREB may play a role in
regulating the basal transcriptional
activation activity of c-Ets1. More-
over, both c-Ets1 and CREB have an
additive effect on the induction of
MUC5AC gene expression, and inhi-
bition of either CREB or c-Ets1 sup-
pressed ATP-induced MUC5AC
gene expression (Fig. 6F), indicating
that both CREB and c-Ets1 are nec-
essary for ATP-induced MUC5AC
transcription. To further confirm
whether c-Ets1 and CREB interact
with the c-Ets1 site in theMUC5AC
promoter, we performed chromatin
immunoprecipitation experiments.
Chromatin was prepared from
ATP-treated cells and then immu-
noprecipitated with an anti-c-Ets1,
CREB, or PLC antibody as a nonrel-
evant antibody. PCRwas performed
on immunoprecipitated DNA after
reversal of cross-linking using prim-
ers specific for the c-Ets1 recogni-
tion site. The PCR product did not
contain a CRE site (851 to844).
The control primers were for a site
2,200 bp upstream of c-Ets1. As
shown in Fig. 6G, the c-Ets1 site was
specifically immunoprecipitated
with the anti-c-Ets1 and CREB anti-
bodies. This suggests that c-Ets1
interacts selectively with CREB at
the c-Ets1 site of theMUC5AC pro-
moter. Taken together, these find-
ings suggest that ATP leads to
enhanced recruitment of c-Ets1 by
CREB to augment MUC5AC tran-
scriptional activation.
DISCUSSION
ATP is tightly regulated and its
extracellular concentration is kept
low by ecto-ATP/ADPases (CD39)
(19). Intracellular ATP concentra-
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tions are in the range of 5–10 mM, and cellular responsiveness
to a pathogen increases the amount of ATP in the pericellular
space by exocytosis (20, 21). Thus, the concentration of ATP
affects physiological cellular homeostasis. Because most of the
literature on the role of ATP in inflammation is focused on the
secretion of inflammatory mediators such as eosinophil cati-
onic protein, radical oxygen intermediates, and IL-8 (22, 23),
the effect of extracellularATPonmucin gene expression during
inflammation remains a matter of speculation. In particular,
there have been no reports on ATP-induced MUC5AC gene
expression in the airway until now, although UTP was found to
induce gene expression of MUC5B, but not MUC5AC, in
human tracheobronchial epithelial cells (24). Accordingly, we
hypothesized that extracellular ATP responses may provide
additional insight intoMucin production during inflammation.
First, we investigated the effect of ATP on MUC5AC gene
expression in normal human nasal epithelial cells. As shown in
Fig. 1, ATP increasedMUC5AC gene expression in NHNE and
NCI-H292 cells in a dose- and time-dependent manner.
Understanding the biochemical characteristics of the PDZ
domain in PLCwill provide additional insight into the molec-
ular signaling mechanism that leads to protein complex forma-
tion. Although previous studies have reported that key amino
acids of the PDZ domain, namely PLC3, Thr-1232, and Leu-
1234, are involved in the binding of Na/H exchanger regu-
latory factor 2 in COS7 cells, and the binding of Shank2 during
mGluR-mediated Ca2 signaling in HN33 hippocampal cells
(8, 15), our results show that the binding activity of the PDZ
domain, and consequently the function of PLC3, is deter-
mined by Leu-1234 in airway epithelial cells. Although most
studies report that Gq- protein activates PLC isoforms,
which in turn activate PKC, our study shows that, at least in the
airway epithelium, Akt, rather than PKC, is activated during
ATP signaling. This result is consistent with the report that
there is direct interaction between PLC-dependent signaling
and the activation of Akt in astrocytoma cells (25). They dem-
onstrated that G-protein-coupled receptor-mediated activa-
tion of Akt was inhibited by wortmannin, suggesting that phos-
phatidylinositol 3-kinase appears to function in this pathway
but not PKC. They also demonstrated that Akt has been acti-
vated by direct activation of the G-protein  subunit-sensitive
phosphatidylinositol 3-kinase  and p110 isoforms (25).
These observations indicate that PKC may not be involved in
the ATP-stimulated signaling pathway in the airway epithelial
cells. Furthermore, we also examined how extracellular ATP
induces MUC5AC gene expression in the nucleus. In our pre-
vious studies, MSK1 and RSK1 were identified as intranuclear
molecules involved in cytokine-inducedmucin gene expression
(16, 26). Because these proteins are tightly regulated by MAPK
in NHNE cells, their effects on ATP-mediated proinflamma-
tory signaling also need to be elucidated. As shown in Fig. 4,
RSK1 is involved in the ATP-mediated signaling pathway, but
MSK1 is not, suggesting that the signaling pathways leading to
MUC5AC gene expression are distinct and depend on the type
of stimuli and cell lines used. The question of what molecule
could mediate this signaling event in the nucleus then arises.
We examined CREB because it is known to be regulated by
RSK1 (16). We demonstrated that ATP-activated RSK1 is
required for activation of CREB (Fig. 4B). Interestingly, even
though CREB is involved in the ATP signaling pathway, the
950/929 region of theMUC5AC promoter does not have a
CREB-binding (CRE) site. In our previous article (26), CRE-
mediated luciferase activity, induced by either IL-1 or tumor
necrosis factor- (929/1 construct), was increased by about
3-fold compared with basal activity. In the same study, the
activity of the1376/1 construct decreased luciferase activ-
ity to basal levels, which suggested the presence of another tran-
scription factor in the1376/929 area acting as a suppressor.
In this experiment, although the CRE site (851 to 844) did
not play an important role in ATP-induced MUC5AC tran-
scription, it may have an additive or synergic effect as a result of
interaction with another transcription factor to induce com-
plete expression of MUC5AC (Fig. 5, A and C). To search for
such factor(s), we used a 22-bp sequence (950 to929) with
a high degree of stringency and identified c-Ets1.
In our previous study (26), we demonstrated that CREB is
essential for proinflammatory cytokines-induced MUC5AC
gene expression. However, it seemed that CREB was not suffi-
cient for fully cytokine-induced MUC5AC gene expression. A
transcription factor(s) other thanCREB is required formaximal
ATP–induced expression of theMUC5AC gene in airway epi-
thelium. As seen in Fig. 5, after analyzing the 950/929
region of the MUC5AC promoter, it appears that c-Ets1 may
play a role in ATP-induced MUC5AC transcription. The con-
sensus sequence for c-Ets1 is PuC(C/A)GGA(A/T)GCPy
(GGA(A/T), core sequence) (27, 28). In this consensus
sequence, the GG of the core sequence in the c-Ets1-binding
sitemay be critical for inducingMUC5AC gene expression after
FIGURE 6.CREB canbind and regulate thephosphorylation of c-Ets1 inATP-inducedMUC5ACgene expression.A, cells were transiently transfectedwith
wild-type or siRNA constructs of c-Ets1. Cells were serum-starved and treatedwith ATP (10M) for 24 h, afterwhich cell lysateswere harvested forWestern blot
analysis and real timePCR. *,p0.05 comparedwith control; **,p0.05 comparedwithATP treatment.B, confluent andquiescent cellswere treatedwithATP
(10 M) for the indicated times, and then cell lysates were harvested and analyzed by Western blot using phospho-specific c-Ets1 antibody (Ser-282). Total
c-Ets1was used as a loading control (con). C, cells were transiently transfectedwith awild-type or siRNA construct for RSK1, CREB, or c-Ets1. The cells were then
serum-starvedovernight and treatedwithATP for 10min, afterwhich cell lysateswereharvested forWesternblot analysis.D,an in vitroGSTpulldownassaywas
performed using bacterially expressed GST-wild-type CREB and CREB S133A proteins as exogenous binding partners. Lysates were prepared from NCI-H292
cells treated byATP for 10min, and 1mgof lysatewas incubatedwith 250 nMGST fusion proteins, and themembrane transfers of boundproteinswere probed
with the indicated antibodies. E, confluent and quiescent cells were treated for the indicated times (min) with ATP. Total cell lysates were then immunopre-
cipitatedwith anti-c-Ets1 antibody and blottedwith several antibodies. IP, immunoprecipitation; IB, immunoblotting. F, cells were transiently transfectedwith
a wild-type or siRNA constructs of c-Ets1 or CREB, and cells were then serum-starved and treated with ATP (10 M) for 24 h, after which cell lysates were
harvested for real time PCR. *, p 0.05 compared with control; **, p 0.05 compared with ATP treatment; ***, p 0.05 compared with wild-type c-Ets1 and
wild-type CREB transfectants. G, chromatin prepared from cells with/without ATP treatment was immunoprecipitated using several antisera, and PCR was
performedonDNApurified from input chromatin (Input) or immunoprecipitated chromatin, usingprimerpairs surrounding the c-Ets1 site (didnot containCRE
site) or an upstream site in the MUC5AC promoter. PCR products were visualized by agarose gel electrophoresis and ethidium bromide staining. Anti-PLC
antibody was used as a negative control. Distilled water was used a solvent of ATP as a vehicle control. These figures are representative of three independent
experiments.
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exposure of ATP (Fig. 5B). The c-Ets1 recognition sequence,
which exists at the 938/930 position in theMUC5AC pro-
moter, is recognized by the Ets family of transcription factors
that share a conserved 85-amino acid DNA binding domain
known as the Ets domain (9). Recently, there has been contro-
versy with the role(s) of the Ets factor, because Ets-1 has dual
functions to regulate cellular phenomena as follows: Ca2-de-
pendent phosphorylation of Ets1 results in the loss of DNA
binding activity in murine T cell hybridoma Hd11.2 cells (29),
whereas Ets factor PEA3 can transactivate the proximal region
of the MUC4 promoter and increase MUC4 mRNA levels in
pancreatic cancer cell lines (CAPAN-1 and -2) (30). This dis-
crepancy may due to differences in the type of stimuli or cell
lines used. In this study, both c-Ets1 and CREB had an additive
effect on the induction ofMUC5AC gene expression (Fig. 6F),
showing that both CREB and c-Ets1 play an important role in
ATP-induced MUC5AC transcription. These results suggest
three possibilities as follows: 1) c-Ets1 may be a key factor and
may form a ternary complex forMUC5AC gene expression; 2)
c-Ets1 may be a cofactor recruited by a major transcription
factor such as CREB; or 3) c-Ets1may activate its own pathway.
Li et al. (9) reported that there is a stable interaction between
c-Ets1 and other transcription factors, such as AP-1, NF-B,
and Pax family members in response to diverse signals includ-
ing cytokines, growth factor, and cellular stresses. In Fig. 6C,
c-Ets1 did not affect ATP-induced phosphorylation of CREB,
and RSK1 did not affect ATP-induced phosphorylation of
c-Ets1. Only CREB enhanced the phosphorylation of c-Ets1,
indicating that CREB can regulate c-Ets1 phosphorylation, but
in an RSK1-independent manner.
More interestingly, many reports have shown that c-Ets1 can
bind to CBP/p300, but not CREB, and these authors have sug-
gested that CBP/p300 might mediate interactions between
c-Ets1 and other transcription factors (19–21). Even though
c-Ets1 and CREB are critical transcription factors for erythroid
differentiation (31) and humanCdc212 transcription in human
melanoma cell line A375 cells (11), there was no evidence
whether c-Ets1 may bind to CREB directly. In our system, GST
pulldown, immunoprecipitation, and ChIP assays revealed that
CREB could induce the phosphorylation of c-Ets1, and the
interaction between CREB and c-Ets1 had a synergistic effect
on ATP-inducedMUC5AC gene expression by docking CREB
at the c-Ets1 site of the MUC5AC promoter (Fig. 6). Taken
together, these findings demonstrate that CREB may interact
directlywith the c-Ets1 transcription factor, which is thought to
function as a bridging protein between DNA-binding tran-
scription factors and basal transcription factors, thereby inte-
grating diverse signaling pathways involved in regulating
MUC5AC gene expression.
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